134 related articles for article (PubMed ID: 16678795)
1. Modification of Msx1 by SUMO-1.
Gupta V; Bei M
Biochem Biophys Res Commun; 2006 Jun; 345(1):74-7. PubMed ID: 16678795
[TBL] [Abstract][Full Text] [Related]
2. PIAS1 negatively regulates ubiquitination of Msx1 homeoprotein independent of its SUMO ligase activity.
Song YJ; Lee H
Mol Cells; 2011 Sep; 32(3):221-6. PubMed ID: 21717107
[TBL] [Abstract][Full Text] [Related]
3. Identification of a non-covalent ternary complex formed by PIAS1, SUMO1, and UBC9 proteins involved in transcriptional regulation.
Mascle XH; Lussier-Price M; Cappadocia L; Estephan P; Raiola L; Omichinski JG; Aubry M
J Biol Chem; 2013 Dec; 288(51):36312-27. PubMed ID: 24174529
[TBL] [Abstract][Full Text] [Related]
4. Sumoylated SnoN represses transcription in a promoter-specific manner.
Hsu YH; Sarker KP; Pot I; Chan A; Netherton SJ; Bonni S
J Biol Chem; 2006 Nov; 281(44):33008-18. PubMed ID: 16966324
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of Tbx5-mediated transactivation by SUMO conjugation and protein inhibitor of activated STAT 1 (PIAS1).
Beketaev I; Kim EY; Zhang Y; Yu W; Qian L; Wang J
Int J Biochem Cell Biol; 2014 May; 50():82-92. PubMed ID: 24582888
[TBL] [Abstract][Full Text] [Related]
6. PIAS1 confers DNA-binding specificity on the Msx1 homeoprotein.
Lee H; Quinn JC; Prasanth KV; Swiss VA; Economides KD; Camacho MM; Spector DL; Abate-Shen C
Genes Dev; 2006 Apr; 20(7):784-94. PubMed ID: 16600910
[TBL] [Abstract][Full Text] [Related]
7. Modification of de novo DNA methyltransferase 3a (Dnmt3a) by SUMO-1 modulates its interaction with histone deacetylases (HDACs) and its capacity to repress transcription.
Ling Y; Sankpal UT; Robertson AK; McNally JG; Karpova T; Robertson KD
Nucleic Acids Res; 2004; 32(2):598-610. PubMed ID: 14752048
[TBL] [Abstract][Full Text] [Related]
8. Casein kinase-2-mediated phosphorylation increases the SUMO-dependent activity of the cytomegalovirus transactivator IE2.
Tripathi V; Chatterjee KS; Das R
J Biol Chem; 2019 Oct; 294(40):14546-14561. PubMed ID: 31371453
[TBL] [Abstract][Full Text] [Related]
9. PIAS1 is a GATA4 SUMO ligase that regulates GATA4-dependent intestinal promoters independent of SUMO ligase activity and GATA4 sumoylation.
Belaguli NS; Zhang M; Garcia AH; Berger DH
PLoS One; 2012; 7(4):e35717. PubMed ID: 22539995
[TBL] [Abstract][Full Text] [Related]
10. Role for SUMO modification in facilitating transcriptional repression by BKLF.
Perdomo J; Verger A; Turner J; Crossley M
Mol Cell Biol; 2005 Feb; 25(4):1549-59. PubMed ID: 15684403
[TBL] [Abstract][Full Text] [Related]
11. SUMO E3 ligases are expressed in the retina and regulate SUMOylation of the metabotropic glutamate receptor 8b.
Dütting E; Schröder-Kress N; Sticht H; Enz R
Biochem J; 2011 Apr; 435(2):365-71. PubMed ID: 21288202
[TBL] [Abstract][Full Text] [Related]
12. A Fluorescent In Vitro Assay to Investigate Paralog-Specific SUMO Conjugation.
Eisenhardt N; Chaugule VK; Pichler A
Methods Mol Biol; 2016; 1475():67-78. PubMed ID: 27631798
[TBL] [Abstract][Full Text] [Related]
13. PIAS1 enhances SUMO-1 modification and the transactivation activity of the major immediate-early IE2 protein of human cytomegalovirus.
Lee JM; Kang HJ; Lee HR; Choi CY; Jang WJ; Ahn JH
FEBS Lett; 2003 Dec; 555(2):322-8. PubMed ID: 14644436
[TBL] [Abstract][Full Text] [Related]
14. PIAS proteins promote SUMO-1 conjugation to STAT1.
Ungureanu D; Vanhatupa S; Kotaja N; Yang J; Aittomaki S; Jänne OA; Palvimo JJ; Silvennoinen O
Blood; 2003 Nov; 102(9):3311-3. PubMed ID: 12855578
[TBL] [Abstract][Full Text] [Related]
15. The serine/arginine-rich protein SF2/ASF regulates protein sumoylation.
Pelisch F; Gerez J; Druker J; Schor IE; Muñoz MJ; Risso G; Petrillo E; Westman BJ; Lamond AI; Arzt E; Srebrow A
Proc Natl Acad Sci U S A; 2010 Sep; 107(37):16119-24. PubMed ID: 20805487
[TBL] [Abstract][Full Text] [Related]
16. Targeting the PIAS1 SUMO ligase pathway to control inflammation.
Liu B; Shuai K
Trends Pharmacol Sci; 2008 Oct; 29(10):505-9. PubMed ID: 18755518
[TBL] [Abstract][Full Text] [Related]
17. p53 sumoylation: mechanistic insights from reconstitution studies.
Wu SY; Chiang CM
Epigenetics; 2009 Oct; 4(7):445-51. PubMed ID: 19838051
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of protein inhibitor of activated STAT1 (PIAS1) by MAPK-activated protein kinase-2 inhibits endothelial inflammation via increasing both PIAS1 transrepression and SUMO E3 ligase activity.
Heo KS; Chang E; Takei Y; Le NT; Woo CH; Sullivan MA; Morrell C; Fujiwara K; Abe J
Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):321-9. PubMed ID: 23202365
[TBL] [Abstract][Full Text] [Related]
19. Extracellular signal-regulated kinase 5 SUMOylation antagonizes shear stress-induced antiinflammatory response and endothelial nitric oxide synthase expression in endothelial cells.
Woo CH; Shishido T; McClain C; Lim JH; Li JD; Yang J; Yan C; Abe J
Circ Res; 2008 Mar; 102(5):538-45. PubMed ID: 18218985
[TBL] [Abstract][Full Text] [Related]
20. Post-translational modification of Rta of Epstein-Barr virus by SUMO-1.
Chang LK; Lee YH; Cheng TS; Hong YR; Lu PJ; Wang JJ; Wang WH; Kuo CW; Li SS; Liu ST
J Biol Chem; 2004 Sep; 279(37):38803-12. PubMed ID: 15229220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
